# Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure

> **NCT03389386** · — · COMPLETED · sponsor: **Josko Bozic** · enrollment: 120 (actual)

## Conditions studied

- Heart Failure，Congestive

## Interventions

- **DIAGNOSTIC_TEST:** Blood withdrawal for laboratory analysis
- **OTHER:** Standard-of-care treatment
- **DIAGNOSTIC_TEST:** Transthoracic echocardiography (TTE)

## Key facts

- **NCT ID:** NCT03389386
- **Lead sponsor:** Josko Bozic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-25
- **Primary completion:** 2019-04-16
- **Final completion:** 2019-04-16
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389386, "Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03389386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*